Debray M - Search Results

1

Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.

Weinling E, Sandouk P, Debray M, Scherrmann JM. Weinling E, et al. Among authors: debray m. Int J Clin Pharmacol Ther. 1999 Oct;37(10):503-9. Int J Clin Pharmacol Ther. 1999. PMID: 10543318

2

Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer.

Sandouk P, Serrie A, Urtizberea M, Debray M, Got P, Scherrmann JM. Sandouk P, et al. Among authors: debray m. Clin Pharmacol Ther. 1991 Apr;49(4):442-8. doi: 10.1038/clpt.1991.52. Clin Pharmacol Ther. 1991. PMID: 2015734

3

Efflux of intracellular colchicine in lymphocytes with colchicine-specific Fab fragments.

Chappey ON, Niel E, Debray M, Wautier JL, Scherrmann JM. Chappey ON, et al. Among authors: debray m. J Pharmacol Exp Ther. 1995 Sep;274(3):1072-6. J Pharmacol Exp Ther. 1995. PMID: 7562471

4

Pharmacokinetics of lithium in plasma and red blood cells in acute and chronic intoxicated patients.

Ferron G, Debray M, Buneaux F, Baud FJ, Scherrmann JM. Ferron G, et al. Among authors: debray m. Int J Clin Pharmacol Ther. 1995 Jun;33(6):351-5. Int J Clin Pharmacol Ther. 1995. PMID: 7582387

5

Comparison of colchicine toxicity on different dysmyelinating mutant models.

Urtizberea M, Bourre JM, Debray M, Scherrmann JM. Urtizberea M, et al. Among authors: debray m. Neurotoxicology. 1989 Summer;10(2):211-7. Neurotoxicology. 1989. PMID: 2616063

6

Affinity and dose-dependent digoxin Na+K+ATPase dissociation by monoclonal digoxin-specific antibodies.

Cano NJ, Navarro-Teulon I, Debray M, Piechaczyk M, Scherrmann JM. Cano NJ, et al. Among authors: debray m. Biochem Pharmacol. 1995 Nov 27;50(11):1867-72. doi: 10.1016/0006-2952(95)02080-2. Biochem Pharmacol. 1995. PMID: 8615866

7

Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.

Grene-Lerouge NA, Bazin-Redureau MI, Debray M, Scherrmann JM. Grene-Lerouge NA, et al. Among authors: debray m. Toxicol Appl Pharmacol. 1996 May;138(1):84-9. doi: 10.1006/taap.1996.0101. Toxicol Appl Pharmacol. 1996. PMID: 8658517

8

Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.

Rivière G, Choumet V, Audebert F, Sabouraud A, Debray M, Scherrmann JM, Bon C. Rivière G, et al. Among authors: debray m. J Pharmacol Exp Ther. 1997 Apr;281(1):1-8. J Pharmacol Exp Ther. 1997. PMID: 9103473

9

Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.

Bazin-Redureau M, Pepin S, Hong G, Debray M, Scherrmann JM. Bazin-Redureau M, et al. Among authors: debray m. Toxicol Appl Pharmacol. 1998 Jun;150(2):295-300. doi: 10.1006/taap.1997.8363. Toxicol Appl Pharmacol. 1998. PMID: 9653060

10

Effect of social isolation on the metabolism of morphine and its passage through the blood-brain barrier and on consumption of sucrose solutions.

Coudereau JP, Stain F, Drion N, Sandouk P, Monier C, Debray M, Scherrmann JM, Bourre JM, Francès H. Coudereau JP, et al. Among authors: debray m. Psychopharmacology (Berl). 1999 Jun;144(3):198-204. doi: 10.1007/s002130050994. Psychopharmacology (Berl). 1999. PMID: 10435385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters